Sector: Pharmaceuticals & Biotechnology
|Small Cap
Solara Active Pharma Sciences Ltd.
₹555.65
₹543.75
₹557.00
₹422.00
₹734.40
Markets Today
Historical Performance
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 387.29 | 349 | 313.54 | 319.15 | 273.01 |
| Operating Expense | 329.74 | 311.65 | 278.79 | 262.12 | 230.42 |
| Operating Profit | 57.55 | 37.35 | 34.75 | 57.03 | 42.59 |
| Depreciation | 26.04 | 25.57 | 24.49 | 23.58 | 24.30 |
| Interest | 27.06 | 22.45 | 20.83 | 23.90 | 29.12 |
| Tax | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 9.73 | -17.42 | -10.08 | 10.53 | -4.88 |
₹555.65
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 37.2 | 37.9 | 42 | 42 | 42 | 42 |
| FII | 14.7 | 14.6 | 14.2 | 13.6 | 12 | 11.6 |
| DII | 3.2 | 2.6 | 2.7 | 2.7 | 3.6 | 3.7 |
| Public | 44.9 | 44.8 | 41.1 | 41.7 | 42.4 | 42.7 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 1.11 L | 3.07 L | 36.21% |
| Week | 1.45 L | 10.29 L | 14.13% |
| 1 Month | 77.19 K | 3.5 L | 22.06% |
| 6 Month | 51.2 K | 1.85 L | 27.62% |
Best results last week in YoY net profit and revenue growth
Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
Turnaround Companies: Loss to Profit QoQ
Expensive Performers (DVM)
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Turnaround companies- loss to profit QoQ
Growth in Net Profit with increasing Profit Margin (QoQ)
Increasing Revenue every quarter for the past 2 quarters
Book Value per share Improving for last 2 years
Stock with Low PE (PE < = 10)
RSI indicating price strength
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 18 Aug, 2021 | 3 | FINAL | Equity Share | |
| 19 Nov, 2020 | 4 | INTERIM | 20 Nov, 2020 | Equity Share |
| 28 Jul, 2020 | 2 | FINAL | Equity Share | |
| 06 Aug, 2019 | 5 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹494.20 | ₹6.50 | ₹118 | ₹132.50 | ₹13.78 | ₹18 |
| % Change | 1.54% | -0.61% | -4.84% | 1.85% | -0.93% | -1.37% |
| Revenue TTM (₹ Cr) | - | ₹83.60 | - | ₹287.68 | - | - |
| Net Profit TTM (₹ Cr) | - | ₹-34.95 | - | ₹14.88 | - | - |
| PE TTM | - | -1.50 | 16.20 | 33.00 | - | 6.20 |
| 1 Year Return | 22.61 | 551 | -4.69 | 0.28 | 46.26 | -58.14 |
| ROCE | 28.91 | -5.63 | - | - | - | - |
Influx Healthtech Ltd.
₹ 243.00
-2.72%
Medicamen Organics Ltd.
₹ 24.80
+1.43%
Amrutanjan Health Care Ltd.
₹ 559.75
+0.46%
Innova Captab Ltd.
₹ 842.05
-0.74%
Valiant Laboratories Ltd.
₹ 77.00
+0.16%
Sigachi Industries Ltd.
₹ 20.42
+0.34%
Windlas Biotech Ltd.
₹ 773.05
-2.14%
Vineet Laboratories Ltd.
₹ 35.00
-1.69%
Zim Laboratories Ltd.
₹ 102.50
+2.34%
Medico Remedies Ltd.
₹ 47.95
+0.23%
Dishman Carbogen Amcis Ltd.
₹ 200.00
+2.37%
Lasa Supergenerics Ltd.
₹ 8.09
+1.25%
Advanced Enzyme Technologies Ltd.
₹ 381.15
+1.60%
Bajaj Healthcare Ltd.
₹ 305.00
-0.18%
Ortin Global Ltd.
₹ 15.05
-3.53%
Brooks Laboratories Ltd.
₹ 56.41
+4.99%
RPG Life Sciences Ltd.
₹ 2275.90
-0.78%
Bafna Pharmaceuticals Ltd.
₹ 137.70
+1.98%
Alpa Laboratories Ltd.
₹ 69.15
-0.01%
SMS Pharmaceuticals Ltd.
₹ 365.00
-4.31%
Nectar Lifesciences Ltd.
₹ 12.39
+2.74%
Mangalam Drugs and Organics Ltd.
₹ 29.73
+1.09%
Indoco Remedies Ltd.
₹ 198.53
-0.28%
By signing up I certify terms, conditions & privacy policy